Large-scale information retrieval and correction of noisy pharmacogenomic datasets through residual thresholded deep matrix factorization
Open Access
- 1 May 2025
- journal article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (3)
Abstract
Pharmacogenomics studies are attracting an increasing amount of interest from researchers in precision medicine. The advances in high-throughput experiments and multiplexed approaches allow the large-scale quantification of drug sensitivities in molecularly characterized cancer cell lines (CCLs), resulting in a number of open drug sensitivity datasets for drug biomarker discovery. However, a significant inconsistency in drug sensitivity values among these datasets has been noted. Such inconsistency indicates the presence of substantial noise, subsequently hindering downstream analyses. To address the noise in drug sensitivity data, we introduce a robust and scalable deep learning framework, Residual Thresholded Deep Matrix Factorization (RT-DMF). This method takes a single drug sensitivity data matrix as its sole input and outputs a corrected and imputed matrix. Deep matrix factorization (DMF) excels at uncovering subtle patterns, due to its minimal reliance on data structure assumptions. This attribute significantly boosts DMF’s ability to identify complex hidden patterns among nuisance effects in the data, thereby facilitating the detection of signals that are therapeutically relevant. Furthermore, RT-DMF incorporates an iterative residual thresholding procedure, which plays a crucial role in retaining signals more likely to hold therapeutic importance. Validation using simulated datasets and real pharmacogenomics datasets demonstrates the effectiveness of our approach in correcting noise and imputing missing data in drug sensitivity datasets (open-source package available at https://github.com/tomwhoooo/rtdmf).Keywords
Funding Information
- National Institute of General Medical Sciences of the National Institutes of Health (R01GM134307)
- National Institutes of Health
This publication has 31 references indexed in Scilit:
- Correlating chemical sensitivity and basal gene expression reveals mechanism of actionNature Chemical Biology, 2015
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity DatasetCancer Discovery, 2015
- A New Initiative on Precision MedicineNew England Journal of Medicine, 2015
- Pragmatic issues in biomarker evaluation for targeted therapies in cancerNature Reviews Clinical Oncology, 2014
- Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus OxaliplatinJournal of Clinical Oncology, 2013
- Inconsistency in large pharmacogenomic studiesNature, 2013
- Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer LinesScience Signaling, 2013
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small MoleculesCell, 2013
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012